Protocol Number | Type of Cancer or Study | Intergroup Number | Coordinating Center | Study Status | Closure Date | Treatment Credit | Cancer Control Credit | Followup Credit | Followup Years | Credit Description |
---|---|---|---|---|---|---|---|---|---|---|
00-38 | Intervention Study | Closed | 7/28/2004 | 1 | 0 | Credit increased from 0.5 to 1.0 Cancer Control as of June 1,2003 | ||||
01-06 | Intervention Study | Active | 0 | 1 | ||||||
01-09 | Intervention Study | Closed | 6/24/2005 | 1 | Cancer Control Credit increased from 0.5 to 1.0 as of June 1, 2003. | |||||
150 | Gynecologic | 150 | GOG | CL | 4/14/2005 | 1 | 0 | 0 | 0 | |
1650 | Breast | MDA | CL | 3/31/2002 | 1 | 0 | 0 | |||
1652 | Lymphomas Non-Hodgkin's | MDA | CL | 11/11/2003 | 1 | 0 | 0 | 0 | ||
1691 | Breast | MDA | CL | 3/10/2003 | 1 | 0 | 0 | |||
2006-0841 | DCP Approved | 0 | 1 | 0 | ||||||
3410 | Genitourinary | MDA-3410 | MDA | AC | 1 | 0 | 0 | |||
430 | Lymphomas | MDA | CL | 10/19/2004 | 1 | 0 | 0 | 0 | ||
4450 | Lung Non-Small Cell | MDA | CL | 11/5/2001 | 1 | 0 | 0 | |||
6167 | Hepatic | MDA | CL | 6/20/2005 | 1 | 0 | 0 | 0 | ||
6384 | Leukemia, Acute | MDA | CL | 6/7/2006 | 1 | 0 | 0 | 0 | ||
6459 | Genitourinary | MDA | AC | 1 | 0 | 0 | ||||
6484 | Leukemia, Acute | MDA | CL | 11/1/2006 | 1 | 0 | 0 | 0 | ||
6485 | Lymphomas Non-Hodgkin's | MDA | AC | 1 | 0 | 0 | ||||
6636 | Brain | MDA | AC | 1 | 0 | 0 | 0 | |||
7548 | Lymphomas | MDA | AC | 1 | 0 | 0 | 0 | |||
86 | Lymphomas | MDA | CL | 2/14/2003 | 1 | 0 | 0 | 0 | ||
C87-0004 | Descriptive | Closed | 5/3/1989 | 0 | 0.5 | |||||
C87-0007 | Descriptive | Closed | 9/29/1988 | 0 | 0.2 | |||||
C88-0005 | Intervention Study | Closed | 8/24/1989 | 0 | 0 | |||||
C89-0003 | Intervention Study | Closed | 9/25/1991 | 0 | 0.3 | |||||
C89-0004 | Intervention Study | Closed | 12/19/1991 | 0 | 0 | 0.5 PER FAMILY UNIT | ||||
C89-0005 | Descriptive | Closed | 6/22/1998 | 0 | 0.5 | |||||
C91-0002 | Intervention Study | Closed | 6/30/1999 | 0 | 1 | 0.3 | RTOG 91-15, SWOG 9446, CALGB 9499; 1.0 CREDIT FOR YEAR 1; 0.3 CREDIT FOR ADD'L.YRS | |||
DM90-048 | Genitourinary | CL | 5/13/1993 | 1 | 0 | 0 | 0 | NCI # T90-0119 | ||
DM94-020 | Gastrointestinal | CALGB-9270 | CALGB | CL | 1/3/2000 | 0 | 1 | 0 | 0 | 1 CREDIT FOR YEAR ONE; O.3 Followup Credit FOR ADDITIONAL YEARS. |
DM95-148 | Other | E4Z93 | MDA | CL | 11/29/1999 | 0 | 0.7 | 0 | 0 | CREDIT INCREASED FROM 0.5 TO 0.7 AS OF 06/01/98 |
DM96-248 | Lung | MDA | CL | 6/28/2001 | 1 | 0 | 0 | 0 | ||
DM96-256 | Intervention Study | DM96-256 | Closed | 8/27/2002 | 0 | 0.7 | CREDIT RAISED FROM O.5 TO 0.7 AS OF 06/01/98 | |||
GOG-0126L | Gynecologic | GOG-0126L | GOG | CL | 3/31/2003 | 1 | 0 | 0 | ||
GOG-0126-N | Gynecologic | GOG-0126-N | GOG | CL | 10/1/2004 | 1 | 0 | 0 | ||
GOG-0127Q | Gynecologic | GOG-0127Q | GOG | CL | 6/3/2002 | 1 | 0 | 0 | ||
GOG-0127R | Gynecologic | GOG | CL | 10/1/2004 | 1 | 0 | 0 | 0 | ||
GOG-0129M | Gynecologic | GOG-0129-M | GOG | CL | 10/1/2004 | 1 | 0 | 0 | ||
GOG-0131G | Gynecologic | GOG-0131-G | GOG | CL | 10/1/2004 | 1 | 0 | 0 | ||
GOG-0146L | Gynecologic | GOG-0146-L | GOG | CL | 10/1/2004 | 1 | 0 | 0 | ||
GOG-0146M | Gynecologic | GOG-0146M | GOG | CL | 10/1/2004 | 1 | 0 | 0 | ||
GOG-0150 | Gynecologic | GOG | CL | 10/1/2004 | 1 | 0 | 0 | 0 | ||
GOG-0170C | Gynecologic | GOG | CL | 6/3/2002 | 1 | 0 | 0 | 0 | ||
GOG-0170-E | Gynecologic | GOG-0170-E | GOG | CL | 10/1/2004 | 1 | 0 | 0 | ||
GOG-0176 | Other | GOG | CL | 10/1/2004 | 1 | 0 | 0 | 0 | ||
GOG-0179 | Gynecologic | GOG-0179 | GOG | CL | 9/23/2002 | 1 | 0.5 | 0 | 0 | CC credit for QOL |
GOG-0181B | Gynecologic | GOG-0181B | GOG | CL | 10/1/2004 | 1 | 0 | 0 | 0 | |
GOG-0182 | Gynecologic | GOG-0182 | GOG | CL | 10/1/2004 | 1 | 0 | 0 | ||
GOG-0184 | Gynecologic | GOG-0184 | GOG | CL | 10/1/2004 | 1 | 0 | 0 | ||
GOG-0186C | Gynecologic | GOG | CL | 10/1/2004 | 1 | 0 | 0 | 0 | ||
GOG-0187 | Gynecologic | GOG-0187 | GOG | CL | 10/1/2004 | 1 | 0 | 0 | ||
GOG-0189 | Gynecologic | GOG-0189 | GOG | CL | 8/12/2002 | 1 | 0 | 0 | ||
GOG-0190 | Gynecologic | GOG | CL | 10/1/2004 | 0 | 1 | 0 | 0 | ||
GOG-0191 | Gynecologic | GOG | CL | 10/1/2004 | 1 | 0 | 0 | |||
GOG-0227D | Gynecologic | GOG | CL | 10/1/2004 | 1 | 0 | 0 | 0 | ||
GOG-0229B | Gynecologic | GOG | CL | 7/1/2002 | 1 | 0 | 0 | 0 | ||
GOG-0229C | Gynecologic | GOG | CL | 10/1/2004 | 1 | 0 | 0 | 0 | ||
GOG-0230B | Gynecologic | GOG-0230-B | GOG | CL | 10/1/2004 | 1 | 0 | 0 | ||
GOG-0231B | Gynecologic | GOG | CL | 11/4/2002 | 1 | 0 | 0 | |||
GOG-0277D | Gynecologic | MDA | CL | 10/1/2004 | 1 | 0 | 0 | |||
GOG-128G | Gynecologic | GOG | CL | 10/1/2004 | 1 | 0 | 0 | 0 | ||
GOG-137A | Gynecologic | GOG-137A | GOG | CL | 2/25/2003 | 0.5 | 0.5 | 0 | 0 | O.5 RX CREDIT & 0.5 CC CREDIT |
GOG-161 | Gynecologic | GOG-161 | GOG | CL | 4/19/2004 | 1 | 0 | 0 | ||
GOG-167A/B | Intervention Study | GOG-167A/B | Closed | 2/24/2003 | 1 | PART A - 0.5 CC CREDIT; PART B - 1.0 CC CREDIT | ||||
GOG-171 | Gynecologic | GOG-171 | GOG | CL | 10/1/2004 | 0 | 0.1 | 0 | 0 | |
GOG-173 | Gynecologic | GOG-173 | GOG | CL | 10/1/2004 | 1 | 0 | 0 | ||
GOG-174 | Other | GOG-174 | GOG | CL | 10/1/2004 | 1 | 0 | 0 | ||
GOG-175 | Gynecologic | GOG-175 | GOG | CL | 10/1/2004 | 1 | 0 | 0 | ||
GOG-87K | Gynecologic | GOG | CL | 10/1/2004 | 1 | 0 | 0 | |||
GOG-LAP2 | Gynecologic | GOG-LAP2 | GOG | CL | 10/1/2004 | 1 | 0 | 0 | 0 | |
I91-0001 EXT | Closed | 12/31/2004 | 0.2 | 0.2 is for Extended Follow-up | ||||||
ID91-002 | Intervention Study | Closed | 12/31/1993 | 0 | 0.5 | |||||
ID93-004 | Intervention Study | DCP Approved | 0 | 1 | 0 | |||||
ID94-022 | Intervention Study | Closed | 11/19/1996 | 0 | 0.5 | |||||
ID95-236 | Intervention Study | Closed | 12/16/2003 | 0 | 1 | 0.3 | 0.3 CC FU CREDIT | |||
ID96-222 | Gynecologic | MDA | CL | 3/13/2000 | 1 | 0 | 0 | 0 | ||
ID99-255 | Lymphomas, Hodgkin's Disease | MDA | CL | 6/25/2003 | 1 | 0 | 0 | 0 | ||
MDA-02-23 | Intervention Study | Closed | 2/2/2007 | 0 | 1 | Cancer Control credit increased from 0.5 to 1.0 as of June 1, 2003 | ||||
MDA-03-26 | Intervention Study | Active | 0 | 1 | 0 | 0 | ||||
MDA-03-27 | Intervention Study | Active | 0 | 1 | 0 | |||||
RTOG 99-04 | Gastrointestinal | RTOG 99-04 | RTOG | CL | 3/19/2004 | 1 | 0 | 0 | ||
S0033 | Other | S0033 | SWOG | CL | 9/1/2001 | 1 | 0 | 0 | ||
S9917 | Intervention Study | S9917 | Closed | 11/1/2006 | 1 | 0.3 | ||||
T87-0006 | Lung Non-Small Cell | CL | 10/8/1991 | 1 | 0 | 0 | 0 | |||
T87-0266 | Lung Non-Small Cell | CL | 7/22/1992 | 1 | 0 | 0 | 0 | |||
T87-0267 | Lung Non-Small Cell | CL | 1/6/1995 | 1 | 0 | 0 | 0 | |||
T88-0139 | Lung | CL | 12/20/1991 | 1 | 0 | 0 | 0 | |||
T88-0182 | Gastrointestinal | CL | 12/4/1991 | 1 | 0 | 0 | 0 | |||
T88-0223 | Melanoma | CL | 9/5/1995 | 1 | 0 | 0 | 0 | |||
T88-0224 | Other | CL | 10/25/1995 | 1 | 0 | 0 | 0 | |||
T89-0041 | Other | CL | 5/8/1992 | 1 | 0 | 0 | 0 | |||
T89-0190 | Other | CL | 4/26/1993 | 1 | 0 | 0 | 0 | |||
T90-0009 | Gastrointestinal | CL | 10/13/1992 | 1 | 0 | 0 | 0 | |||
T90-0010 | Other | CL | 10/23/1991 | 1 | 0 | 0 | 0 | |||
T90-0117 | Lung | CL | 5/6/1996 | 1 | 0 | 0 | 0 | |||
T91-0214 | Genitourinary | CL | 7/29/1996 | 1 | 0 | 0 | 0 | DM-91-074 | ||
T92-0007 | Genitourinary | CL | 1/10/1995 | 1 | 0 | 0 | 0 | |||
T92-0107 | Genitourinary | MDA | CL | 1/2/2003 | 1 | 0 | 0 | 0 | ||
T92-0112 | Gastrointestinal | CL | 6/11/1993 | 1 | 0 | 0 | 0 | |||
T92-0114 | Brain | CL | 7/22/1999 | 1 | 0 | 0 | 0 | |||
T92-0140 | Gastrointestinal | CL | 10/28/1993 | 1 | 0 | 0 | 0 | |||
T92-0182 | Other | CL | 10/28/1993 | 1 | 0 | 0 | 0 | |||
T92-0207 | Brain | CL | 2/28/1997 | 1 | 0 | 0 | 0 | |||
T92-0215 | Gynecologic | MDA | CL | 9/19/1998 | 1 | 0 | 0 | 0 | CREDIT FOR ACCRUAL AFTER 6/1/97 | |
T92-0218 | Lung Non-Small Cell | CL | 8/17/1994 | 1 | 0 | 0 | 0 | |||
T93-0011 | Gastrointestinal | CL | 1/1/1994 | 1 | 0 | 0 | 0 | |||
T93-0019 | Other | MDA | CL | 2/16/1996 | 1 | 0 | 0 | 0 | ||
T93-0075 | Gynecologic | MDA | CL | 10/30/1997 | 1 | 0 | 0 | 0 | ||
T93-0076 | Gynecologic | MDA | CL | 8/13/1998 | 1 | 0 | 0 | 0 | ||
T93-0088 | Lymphomas, Hodgkin's Disease | CL | 6/16/2000 | 1 | 0 | 0 | 0 | |||
T93-0165 | Breast | MDA | CL | 1/24/1997 | 1 | 0 | 0 | 0 | ||
T94-0040 | Lymphomas, Hodgkin's Disease | MDA | CL | 6/26/2000 | 1 | 0 | 0 | 0 | ||
T94-0041 | Lymphomas | MDA | CL | 2/12/1997 | 1 | 0 | 0 | 0 | ||
T94-0149 | Melanoma | MDA | CL | 3/10/1998 | 1 | 0 | 0 | 0 | ||
T94-0158 | Gastrointestinal | MDA | CL | 4/30/1996 | 1 | 0 | 0 | 0 | ||
T95-0003 | Gastric | MDA | CL | 7/20/1999 | 1 | 0 | 0 | 0 | ||
T95-0012 | Genitourinary | MDA | CL | 4/24/1997 | 1 | 0 | 0 | 0 | ||
T95-0079 | Other | MDA | CL | 3/15/1999 | 1 | 0 | 0 | 0 | ||
T95-0102 | Sarcoma | MDA | CL | 4/2/1997 | 1 | 0 | 0 | 0 | ||
T96-0009 | Gastrointestinal | MDA | CL | 3/2/1998 | 1 | 0 | 0 | 0 | ||
T96-0034 | Gastrointestinal | MDA | CL | 3/2/1998 | 1 | 0 | 0 | 0 | ||
T97-0023 | Genitourinary | MDA | CL | 6/9/2000 | 1 | 0 | 0 | 0 | ||
T97-0069 | Genitourinary | T97-0069 | MDA | AC | 1 | 0.5 | 0 | 0 | 0.5 CC CREDIT FOR QOL | |
T97-0101 | Lymphomas | MDA | CL | 10/25/2002 | 1 | 0 | 0 | 0 | ||
T97-0103 | Lymphomas Non-Hodgkin's | MDA | CL | 6/27/2002 | 1 | 0 | 0 | 0 | ||
T97-0113 | Gastrointestinal | MDA | CL | 1/31/2000 | 1 | 0 | 0 | 0 | ||
T98-0018 | Gastrointestinal | MDA | CL | 10/28/1999 | 1 | 0 | 0 | 0 | ||
T99-0046 | Lung Non-Small Cell | T99-0046 | MDA | CL | 2/15/2006 | 1 | 0 | 0 | ||
T99-0103 | Gastrointestinal | MDA | CL | 2/19/2003 | 1 | 0 | 0 |